Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Forschen mit Partnern in Afrika
© Michael Hölscher

Tuberculosis: Research with partners in Africa

The German Center for Infection Research (DZIF) has been playing a significant role in one of five new African-German research networks. Under the name “TB-Sequel”, the BMBF has been funding research

Die M. tuberculosis „sliding clamp“ (DnaN) im Komplex mit (Cyclohexyl-)Griselimycin.
© HZI/Peer Lukat

New hope in the fight against tuberculosis

According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each

Sandra Junglen
© Dr. Sophie Köndgen/Beuth Hochschule für Techn

Researchers discover two new groups of viruses

Researchers at the University of Bonn and the German Center for Infection Research (DZIF) have discovered two new groups of viruses within the Bunyavirus family in the tropical forest of Ivory Coast

St. aureus
© NIAID

Project start: New active substance targeting dreaded hospital pathogens

In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded

Tuberkulosemedikamente
© FZ Borstel

New online consultation service for tuberculosis initiated

The DZIF has initiated an online consultation service for treating cases of multidrug-resistant tuberculosis. Here, doctors can submit their cases and get advice for further treatment from experts at

Antikörper gegen HIV
© Zach Veilleux/Rockefeller University

Fighting HIV with antibodies

30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome AIDS, and despite intensive research, no vaccine or cure has yet been found. An international team of

Ebola virus
© CDC

Initial results of the Ebola vaccine trials in Africa and Europe

The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available. At the Hamburg-Eppendorf University Medical Center (UKE), in Geneva

Günter Fröschl
© Günter Fröschl

“Humanitarian aid is not haphazard work done by over-motivated cowboys”

DZIF infectious disease and tropical medicine specialist Günter Fröschl (42), from Munich, spent two months in Liberia from December last year, to help with the largest Ebola epidemic seen to date

Cologne Infectologist honoured

DZIF researcher Oliver Cornely has been elected as a Fellow of the American Academy of Microbiology (AAM) in honour of his achievements in the field of life-threatening infections in immunocompromised

MERS coronavirus: “No risk to the public”

A patient who had contracted the dangerous MERS coronavirus in Abu Dhabi gave rise to public concern in Osnabrück this weekend. Many people fear a spread of the pathogen, which causes severe pneumonia